Brief: Adaptive Biotechnologies Reports Fourth Quarter 2022 Results, Provides 2023 Outlook
14/02/2023 21:19
Feb 14 (Reuters) - Adaptive Biotechnologies Q4 EPS USD -0.28 * Q4 net income USD -40.169 million * Outlook FY revenue USD 205-215 million * Q4 revenue USD 55.198 million * Q4 adjusted EBITDA USD -19.6 million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile